Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001029142-25-000117
Filing Date
2025-08-07
Accepted
2025-08-07 16:14:43
Documents
80
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-20250630.htm   iXBRL 10-Q 1722568
2 EX-31.1 dvax-20250630xex311.htm EX-31.1 10345
3 EX-31.2 dvax-20250630xex312.htm EX-31.2 10677
4 EX-32.1 dvax-20250630xex321.htm EX-32.1 6102
5 EX-32.2 dvax-20250630xex322.htm EX-32.2 6086
  Complete submission text file 0001029142-25-000117.txt   8696611

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20250630.xsd EX-101.SCH 58097
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dvax-20250630_cal.xml EX-101.CAL 84374
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dvax-20250630_def.xml EX-101.DEF 262540
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20250630_lab.xml EX-101.LAB 732495
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20250630_pre.xml EX-101.PRE 513982
83 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20250630_htm.xml XML 1296765
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 251194198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)